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Background:  Despite  recent  advances  in  bone  tissue  engineering,  efﬁcient  bone  formation  and  vascula-
rization  remains  a challenge  for clinical  applications.
Hypothesis:  The  aim of  this  study  was to  investigate  if the  osteoblastic  differentiation  of human  mesenchy-
mal stromal  cells  (MSCs)  can be enhanced  by  co-culturing  them  with  peripheral  blood  (PB)  mononuclear
cells  (MNCs),  with  and without  vascular  endothelial  growth  factor  (VEGF),  a coupling  factor  of  bone
formation  and  angiogenesis.
Materials  and methods:  Human  bone  marrow  (BM)  derived  MSCs  were  co-cultured  with  PB-MNCs  in
osteogenic  medium  with  or without  VEGF.  Osteoblastic  differentiation  and  mineral  deposition  were
studied  by  staining  for alkaline  phosphatase  (ALP),  and  von  Kossa,  respectively,  and  measurements
for  ALP  activity  and  calcium  concentration  (Ca).  Cell  proliferation  was  assayed  with  Alamar  blue.  The
mechanism(s)  were  further  studied  by Transwell® cell culture  experiments.
Results:  Both  ALP  and  mineralization  (von Kossa  and  Ca)  were  signiﬁcantly  higher  in the MSC-MNC  co-
cultures  compared  to plain  MSC  cultures.  VEGF  alone  had  no  effect  on  osteoblastic  differentiation  of
MSCs,  but  further  enhanced  differentiation  in  co-culture  settings.  The  mechanism  was  shown  to  require
cell-cell  contact  between  MSCs  and MNCs and  the  factors  contributing  to further  differentiation  appear
to  be soluble.  No differences  were  observed  in  cell  proliferation.
Conclusion:  Our  study  demonstrates  that the  in  vitro  ALP  activity  and  mineralization  of human  BM-MSCs  is
more efﬁcient  in  the  presence  of  PB-MNCs,  and  exogenously  added  VEGF  further  enhances  the  stimulatory
effect.  This  indicates  that  PB-MNCs  could  be  a potential  cell  source  in  development  of co-culture  systems
for novel  tissue  engineering  applications  for enhanced  bone  healing.
Level  of evidence:  Level  IV. Experimental  research  study.
© 2015  Elsevier  Masson  SAS.  All  rights  reserved.. Introduction
Tissue engineering has a great promise in bone repair, but for
ell-based bone reconstruction to reach the clinic, more efﬁcient
echniques for osteoblastic differentiation and bone formation
re needed. Bone marrow (BM) derived mesenchymal stromal
ells (MSCs) are an attractive cell source for osteoprogenitors
1], but angiogenesis is central in bone development and frac-
ure healing, as well as in graft survival after implantation [1,2].
herefore, the synergistic crosstalk between MSCs and endothelial
ells, inﬂuencing both angiogenesis and osteogenesis, has gained
∗ Corresponding author. Tel.: +358443371988; fax: +358 2 231 0320.
E-mail address: kvjoen@utu.ﬁ (K. Joensuu).
http://dx.doi.org/10.1016/j.otsr.2015.01.014
877-0568/© 2015 Elsevier Masson SAS. All rights reserved.interest as a potential solution for improved bone tissue engineered
therapies.
Several studies have shown that endothelial cells enhance
the osteogenic differentiation of MSCs in vitro and in vivo [3–5].
In addition, MSCs stimulate survival and growth of endothelial
cells through production of paracrine signals, including vascular
endothelial growth factor (VEGF) [6]. Endothelial progenitor cells
are found among the CD34-positive fraction of peripheral blood
(PB) mononuclear cells (MNC) [7], and have recently been shown
important for angiogenesis and bone formation during clinical frac-
ture healing [2]. Furthermore, clinical trials have demonstrated
positive outcomes using PB or BM derived MNC-fractions in the
repair of long-bone defects and non-unions [8,9].
VEGF is an important factor in bone biology, needed both
in angiogenesis and in ossiﬁcation of new bone, and enhances
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racture healing [10,11]. Despite active research, the exact mech-
nisms of VEGF in coupling bone formation and angiogenesis are
ot deﬁned [10]. Recent data suggests that bone tissue includes spe-
iﬁc endothelial cell and vessel subtypes that couple angiogenesis
nd osteogenesis, indicating a central role for VEGF [12]. It has also
een reported that VEGF produced by osteoblastic cells promotes
steoblast and inhibits adipocyte differentiation [13], indicating
n autocrine feedback mechanism in osteoblasts [14]. VEGF also
ppears to contribute to paracrine action in osteoblast-endothelial
ell crosstalk [15].
We  have recently demonstrated that co-culture of human PB-
NCs and BM-MSCs leads to endothelial cell differentiation and
ormation of vessel-like tubular structures in vitro, even in the
bsence of exogenously supplied growth factors [16]. The purpose
f the current study was to investigate if co-culturing of MSCs with
B-MNCs enhances osteoblastic differentiation, either in the pres-
nce or absence of VEGF. We  hypothesized that PB-MNCs would
ave a positive inﬂuence on bone formation, providing a potential
ell source for enhanced osteogenesis and angiogenesis for clinical
pplications.
. Materials and methods
Human BM-MSCs were isolated from eight donors (Table 1)
s described previously [17]. Brieﬂy, BM was aspirated and
NCs were isolated by density gradient centrifugation (Ficoll
aque Plus, Amersham Pharmacia, UK), seeded at 2 × 106 cells
er 25 cm2 culture ﬂask and cultured in basal medium con-
isting of -MEM (Gibco® Life Technologies, UK), 10% fetal
ovine serum (FBS, certiﬁed, US-origin, 16000-044, Gibco®) and
00 IU/mL penicillin and 100 g/mL streptomycin (PS, Gibco®).
on-adherent cells were removed after 48 hours and fresh medium
as added. Thereafter half of the medium was  changed every
–4 days. Upon sub-conﬂuency, plastic-adherent MSCs were har-
ested using trypsin/EDTA and re-plated at 1000 cells/cm2. Criteria
or identifying MSCs included phenotype (CD105+, CD73+, CD90+,
D45−, CD14−), proliferation through several passages, as well
s osteogenic, chondrogenic, and adipogenic differentiation, as
escribed earlier [17]. Cells at passage 2-5 were used for the exper-
ments.
For MSC-MNC co-cultures, MSCs were seeded into 24-w tissue
ulture plates (4000 cells/cm2). After ﬁve days, PB samples (aver-
ge volume 40 mL)  were drawn from healthy volunteers (n = 3, age
2–27) and MNCs were isolated by Ficoll centrifugation. The exper-
mental setup included four different groups:
MSCs in osteogenic (OB) medium;
MSCs and MNCs in OB medium;
MSCs in OB medium + VEGF;
MSCs and MNCs in OB medium + VEGF.
Each group consisted of four replicate samples (wells). MNCs
1 × 105/cm2) were added to groups 2 and 4. The OB medium
able 1
emographic data of MSC  donors.
Donor Gender Age (years) Status
#1 F 70 Hip fracture
#2  F 21 Healthy
#3  F 22 Healthy
#4  F 19 Ankle fracture
#5 F 60 Ankle fracture
#6 F 72 Hip osteoarthritis
#7  M 51 Ankle fracture
#8 F 23 Tibia fracture Surgery & Research 101 (2015) 381–386
consisted of basal medium supplemented with 10 mM Na--
glycerophosphate (Merck), 0.05 mM ascorbic acid-2-phosphate
(Sigma-Aldrich). Dexamethasone (10−7 M)  was included for the
ﬁrst week [18]. Recombinant human VEGF-A (R&D Systems, Min-
neapolis, USA) was added at 5 ng/mL to groups 3 and 4. Half of
the medium was changed every 4–5 days and hVEGF-A was added
freshly. Co-cultures of MSCs and MNCs in basal medium as well as
cultures of plain MNCs in OB-medium were included as controls.
Since we have previously demonstrated that MSC-MNC interac-
tions lead to endothelial cell formation [16], we wanted to evaluate
if preceding endothelialization could inﬂuence the osteoblastic dif-
ferentiation in MSC-MNC co-cultures. Therefore, MSCs and MNCs
were ﬁrst co-cultured in basal medium for two weeks before
switching to OB medium with VEGF. In these experiments, MSCs
from donors #1 and #2 were used in 4 parallel samples, cultures
were otherwise performed as described above.
To study if enhanced osteoblastic differentiation in VEGF-
supplemented co-cultures requires cell-cell contact between MSCs
and MNCs, and if the osteogenic factors produced by these cells
are soluble, we performed Transwell® culture experiments using
0.4 m inserts (Translucent, High Density PET Membrane, BD
Falcon). MSC  alone, or MSC-MNC co-cultures were seeded in OB-
medium supplemented with VEGF in four parallel samples in the
lower well. MNCs were seeded either alone or as co-cultures with
MSCs in upper cell culture inserts. As a control, MSC-MNC co-
culture with an empty insert was used. MSCs from donor#2 were
used in these experiments.
Osteoblastic differentiation was analyzed after two  weeks of
culture by staining for alkaline phosphatase (ALP) using a cyto-
chemical kit (86-R, Sigma-Aldrich). After four weeks, bone nodule
formation was  evaluated by von Kossa staining for deposited
calcium. The ALP and von Kossa stained areas were quanti-
ﬁed using an automated image analysis as described earlier
[18].
ALP activity at two  weeks and calcium concentration at four
weeks were determined in cell lysates from four replicate wells
as previously described [19]. We also evaluated cell prolifera-
tion by assessing the metabolic activity of growing cells at 7, 14,
21 and 28 days of culture using AlamarBlue® assay (Invitrogen,
Carlsbad, CA) according to manufacturer’s instructions, in four
replicates/group. Fluorescence counts were furthermore used to
quantify the speciﬁc ALP activities.
For statistical analyses, results from MSCs in OB medium group
were pairwise compared to other groups using the Student’s t-test.
For analysis of ALP activities or calcium concentrations we used
MSCs from ﬁve to three different donors (donors #1-5 and donors
#6-8). Von Kossa and ALP-stainings were analyzed from donors #1-
3. Each culture condition (group) consisted of four replicate wells.
Data is presented as mean ± SD and a P-value <0.05 is considered
statistically signiﬁcant.
3. Results
As a measure of osteogenic differentiation, the strongest ALP
staining was  observed in the MSC-MNC co-cultures supplemented
with exogenous VEGF (Fig. 1a), which was conﬁrmed by quantify-
ing the positively-stained surface areas. No staining was observed
when MSCs were cultured in basal medium (Fig. 1b). For all three
donors, the strongest ALP expression was  seen in co-cultures with
VEGF-supplemented OB medium. This effect was statistically sig-
niﬁcant compared to MSCs cultured in OB medium without MNCs
and VEGF when MSCs from young donors (#2 and #3) were used
(Fig. 1b), but in co-cultures with MSCs from donor #1 this trend
was not statistically signiﬁcant due to high variation (Fig. 1b). From
all donors, the highest Ca concentrations were observed in MSC-
MNC  co-cultures supplemented with exogenous VEGF (Fig. 1c).
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Fig. 1. ALP-stainings of MSC  cultures (a) were performed after two weeks and the positively stained surface areas of samples from three different donors (#1-3) were
q d after
V
I
i
g
d
t
s
(
n
e
p
i
b
A
i
A
i
T
euantiﬁed (b) (P = 0.001 for #2 and P = 0.04 for #3). Calcium levels (c) were measure
EGF  supplementation and P < 0.001 for #6 and #8 without VEGF).
nterestingly, MSC  from two donors showed a signiﬁcant increase
n Ca deposition also in co-cultures without VEGF (Fig. 1c).
No differences were observed in cell proliferation between
roups during ﬁrst two weeks of culture in any of the three MSC
onors used in these experiments (Fig. 2), suggesting that MSCs are
he only proliferating cells in these cultures.
ALP activity was signiﬁcantly higher in MSC-MNC co-cultures
upplemented with exogenous VEGF when compared to control
MSCs in OB medium) (Fig. 3). Enzymatic ALP activities were not
ormalized against protein or DNA content, since those param-
ters are skewed by the unequal cell numbers in co-cultures vs.
lain MSC-cultures. Therefore, we calculated speciﬁc ALP activity
n a single MSC  donor (#2) in relation to cell proliferation (Alamar
lue ﬂuorescence counts at 2 weeks) and conﬁrmed that enzymatic
LP activity (as counts at 405 nm)  (Fig. 3a) and speciﬁc ALP activ-
ty (Fig. 3b) showed a similar response. Due to high variation in
LP levels between different MSC  donors, we calculated ALP activ-
ty (counts at 405 nm)  as % of control separately for each donor.
he pooled data veriﬁed that ALP activities were signiﬁcantly high-
st in the MSC-MNC co-cultures supplemented with exogenous
Fig. 2. Cell proliferation analyzed by Alamar Blue assay using M 4 weeks of culture (P = 0.012, 0.017 and 0.001 for #6, #7 and #8, respectively, with
VEGF (Fig. 3c). No ALP activity was detected when PB-MNCs
were cultured alone in OB medium either with or without VEGF
(Fig. 3d).
The highest ALP activity was observed in those MSC-MNC co-
cultures where OB medium was  added from the start of the
co-culture period. ALP-activities were signiﬁcantly lower when
co-cultured in basal medium for two  weeks before OB induction
(Fig. 4). This indicates that in addition to cell-cell interactions
between MSCs and MNCs the components of OB  medium are crucial
in mediating the positive effects on differentiation.
Physical contact was shown to be needed between MSCs
and MNCs to enhance OB-differentiation in VEGF-supplemented
co-cultures (Fig. 5). MSCs and MNCs in VEGF supplemented
OB-medium separated with the permeable membrane showed
signiﬁcantly lower ALP activities after two weeks compared to co-
cultures (Fig. 5). In addition, factors produced after cell-cell contact
appear to be soluble, as MSCs and MNCs co-cultured in the upper
compartment of the transwell system enhanced OB-differentiation
of the monocultured MSCs isolated by the membrane in the lower
wells (Fig. 5).
SCs from three different donors (a: #1, b: #2 and c: #3).
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Fig. 3. a: quantiﬁcation of cellular ALP activity as absorbance at 405 nm (P = 0.007, 0.0047 and 0.008, respectively); b: speciﬁc ALP activity (P = 0.015, 0.02 and 0.047,
respectively); c: as % of control (P < 0.001), after two  weeks of culture. Mean ALP activities in MSC  cultures of ﬁve donors (#1-5) presented as % of control (MSCs in OB
medium) (c). MNC-monocultures were cultured with or without osteoblastic supplements and/or VEGF (d).
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o  co-cultures were OB-induction was started right after plating the cells (***P < 0.0
. Discussion
Here we demonstrate that a co-culture of human BM-MSCs
ith PB-MNCs in osteogenic medium supplemented with VEGF
eads to enhanced osteoblastic differentiation. VEGF potentiates
he osteoblastic differentiation assessed by ALP expression and Ca-
oncentrations in the MSC-MNC co-cultures, while it has no effect
n MSCs cultured alone in osteogenic medium.PB-MNCs seem as an interesting endothelial progenitor cell
ource for tissue engineering [7,8]. The PB-MNC-fraction is a mix  of
everal cell types and the level of cells and cytokines differ between
onors [20]. CD34+ and CD14+ MNC-populations are known forl medium followed by two additional weeks in OB-medium. ALP activity compared
their pre-angiogenic properties [7] and the use of PB-MNCs for tis-
sue engineered bone constructs is further supported by evidence
for containing a pre-osteoblastic cell population [2]. PB as a cell
source is ideal for its easy availability, although CD34+ and CD14+
cells are rather rare populations among MNCs [20].
We observed no ALP activity or mineralization of the plain
MNCs cultured with osteogenic supplements, indicating that MSCs
are the main pre-osteoblastic cells in the co-culture rather than
MNCs. Since we  used the whole PB-MNC-fraction instead of
puriﬁed CD14+/CD34+ progenitor cells in the co-cultures we can-
not fully conclude which cell type(s) in the MNC-fraction were
responsible for inducing the stimulatory effect on osteoblastic
K. Joensuu et al. / Orthopaedics & Traumatology:
Fig. 5. MSCs and MNCs were cultured in Transwell® cell culture inserts in OB-
medium supplemented with VEGF. MSCs were cultured in inserts (upper level)
or cell culture wells (bottom) as monocultures or co-cultured with MNCs. After
t
(
d
w
t
f
f
o
t
o
d
O
t
f
d
a
m
a
r
M
i
s
c
a
c
i
c
c
f
p
i
m
a
f
[
[11] Keramaris NC, Calori GM,  Nikolaou VS, Schemitsch EH, Giannoudis PV. Fracturewo weeks of culture, ALP activities of the cells in culture wells were measured
**P  = 0.002, *P = 0.03).
ifferentiation. However, there is data showing that the CD14+ cells
ould be the central players inducing the osteoblastic differentia-
ion of BM-MSCs via cell-contact dependent production of soluble
actors [21,22].
Recent data also suggests that VEGF stimulates osteoblastic dif-
erentiation of MSCs by intracellular mechanism [13], supporting
ur ﬁndings. Behr et al. showed that locally applied VEGF increased
he osteogenic healing capacity of human MSCs by promoting
steoblastic and endothelial cell differentiation [23]. However, we
id not observe any differences between the plain MSCs cultured in
B-medium, or OB-medium supplemented with VEGF, indicating
hat the mechanism requires the presence of cells from the MNC-
raction, such as CD34+ or CD14+ cells. MSCs have indeed been
escribed to have a CD14-crossreactive epitope [24] demonstrating
 cell-cell contact dependent interaction mechanism.
We  observed that after co-culturing MSCs and MNCs in basal
edium for two weeks, the osteoblastic differentiation was  not
s efﬁcient as in co-cultures were OB-induction was  started
ight after adding the MNCs. We  have previously shown that
SCs can stimulate endothelial cell differentiation of PB-MNCs
n co-cultures with basal medium [16]. Results of the present
tudy further indicate that osteoinductive components and mono-
yte/macrophage lineage cells, rather than the endothelial cells,
re needed for the strong osteoblastic differentiation in the
o-cultures.
Our results show that physical contact between MSCs and MNCs
s essential for the strong induction of bone formation in the co-
ulture settings and that the osteogenic factors produced by the
ells are soluble. MSCs are indeed shown to produce pro-angiogenic
actors, such as ﬁbroblast growth factor 2 (FGF-2) and bone mor-
hogenetic protein 2 (BMP-2) in co-cultures of MSCs and EPCs [25],
ndicating that these factors could also be relevant in our experi-
ental setup. In addition to their pro-angiogenic properties, BMP-2
nd FGF-2 are inducers of osteogenesis [25]. Production of these
actors decreases during the osteoblastic differentiation process
[ Surgery & Research 101 (2015) 381–386 385
[26], which might indicate that VEGF might turn the “switch” back-
wards and increases the production of pro-angiogenic factors, thus
enhancing osteoblastic differentiation of MSCs in the co-cultures.
We used MSCs from eight different donors including patients
of different gender, age and condition, which obviously causes
variation to the results and weakens the statistical power when
compared e.g. to the use of a single batch of commercially available
MSCs. However, when aiming to the clinic and use of patient-
derived cells, the interindividual variation cannot be avoided. We
observed that ALP-activities and Ca-levels were highest in young
patients’ cells, supporting the well described higher differentiation
potential of cells from younger individuals.
The MSC-MNC co-culture system is a simple method to enhance
the osteoblastic differentiation of MSCs. Furthermore, it includes
many types of progenitor cells, which are essential for angiogenesis
and bone regeneration to take place after bone damage. Therefore,
this method could have potential in the development of cell-based
applications for bone tissue engineering.
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